Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
NCT05652205Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2022
- Primary completion
- Sep 2025
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 3 trial of linaclotide in functional constipation (FC), chronic idiopathic constipation (CIC), sponsored by AbbVie Inc.. Started Dec 2022; status: completed.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT05652205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05652205.